Concepedia

Carmen Baccarini

CB

Statistics

Publications

10

Citations

314

H-Index

10

Active since

2013

Affiliations

GlaxoSmithKline (United States)(Current)

GlaxoSmithKline (Belgium)

Mount Carmel Health

Far Eastern University

Utah Tech University

Carmen Baccarini is an author at GlaxoSmithKline (United States) specializing in vaccine safety, vaccination, and covid-19 epidemiology.

Top concepts

Publications per year

2013–2023

10

Publications

10

Efficacy of the adjuvanted subunit protein COVID-19 vaccine, SCB-2019: a phase 2 and 3 multicentre, double-blind, randomised, placebo-controlled trial

Lulu Bravo, Igor Smolenov, Htay Htay Han et al. · The Lancet · 2022 · 112 citations · Full text

, , +9

Five-year Antibody Persistence and Booster Response to a Single Dose of Meningococcal A, C, W and Y Tetanus Toxoid Conjugate Vaccine in Adolescents and Young Adults

Roger Baxter, Yaela Baine, Devayani Kolhe et al. · The Pediatric Infectious Disease Journal · 2015 · 49 citations

Five-year Antibody Persistence and Booster Response After 1 or 2 Doses of Meningococcal A, C, W and Y Tetanus Toxoid Conjugate Vaccine in Healthy Children

Nicola P. Klein, Yaela Baine, Devayani Kolhe et al. · The Pediatric Infectious Disease Journal · 2016 · 30 citations

Comparison of the Safety and Immunogenicity of a Novel Quadrivalent Meningococcal ACWY-Tetanus Toxoid Conjugate Vaccine and a Marketed Quadrivalent Meningococcal ACWY-Diphtheria Toxoid Conjugate Vaccine in Healthy Individuals 10-25 Years of Age

Scott A. Halperin, Yaela Baine, Joseph B. Domachowske et al. · Journal of the Pediatric Infectious Diseases Society · 2013 · 24 citations · Full text

Safety and Immunogenicity of a Quadrivalent Meningococcal Conjugate Vaccine in Healthy Meningococcal-Naïve Children 2–9 Years of Age: A Phase III, Randomized Study

Carmen Baccarini, Michael Simon, Donald M. Brandon et al. · The Pediatric Infectious Disease Journal · 2020 · 23 citations · Full text

Rows per page

1–5 of 10